questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Ureohydrolases
Ureohydrolases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Ureohydrolases : Questions médicales les plus fréquentes",
"headline": "Ureohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Ureohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-02",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Ureohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Arginase",
"alternateName": "Arginase",
"url": "https://questionsmedicales.fr/mesh/D001119",
"about": {
"@type": "MedicalCondition",
"name": "Arginase",
"code": {
"@type": "MedicalCode",
"code": "D001119",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.913.292"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Ureohydrolases",
"alternateName": "Ureohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D014512",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "M Sinn",
"url": "https://questionsmedicales.fr/author/M%20Sinn",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de."
}
},
{
"@type": "Person",
"name": "L Riede",
"url": "https://questionsmedicales.fr/author/L%20Riede",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "J R Fleming",
"url": "https://questionsmedicales.fr/author/J%20R%20Fleming",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "D Funck",
"url": "https://questionsmedicales.fr/author/D%20Funck",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Konstanz, Konstanz, Germany."
}
},
{
"@type": "Person",
"name": "H Lutz",
"url": "https://questionsmedicales.fr/author/H%20Lutz",
"affiliation": {
"@type": "Organization",
"name": "Department of Biology, University of Konstanz, Konstanz, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Artificial intelligence software in pulmonary nodule assessment.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/36369818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/14782715221123856"
}
},
{
"@type": "ScholarlyArticle",
"name": "A refactoring categorization model for software quality improvement.",
"datePublished": "2023-11-02",
"url": "https://questionsmedicales.fr/article/37917752",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0293742"
}
},
{
"@type": "ScholarlyArticle",
"name": "Bioimage informatics: Investing in software usability is essential.",
"datePublished": "2023-07-31",
"url": "https://questionsmedicales.fr/article/37523379",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pbio.3002213"
}
},
{
"@type": "ScholarlyArticle",
"name": "The CCP4 suite: integrative software for macromolecular crystallography.",
"datePublished": "2023-05-30",
"url": "https://questionsmedicales.fr/article/37259835",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1107/S2059798323003595"
}
},
{
"@type": "ScholarlyArticle",
"name": "The impact of software updates on accuracy of intraoral scanners.",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37061664",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12903-023-02926-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Ureohydrolases",
"item": "https://questionsmedicales.fr/mesh/D014512"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Ureohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Ureohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Ureohydrolases",
"description": "Comment diagnostiquer une déficience en ureohydrolases ?\nQuels tests sont utilisés pour évaluer l'activité des ureohydrolases ?\nQuels symptômes indiquent un problème avec les ureohydrolases ?\nLes tests génétiques sont-ils utiles pour les ureohydrolases ?\nComment l'historique médical aide-t-il au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Software&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Ureohydrolases",
"description": "Quels sont les symptômes d'une accumulation d'urée ?\nComment se manifeste une hyperammoniémie ?\nLes symptômes varient-ils selon l'âge ?\nQuels signes cliniques sont associés à une déficience en ureohydrolases ?\nPeut-on avoir des symptômes sans déficience enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Software&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Ureohydrolases",
"description": "Peut-on prévenir les troubles liés aux ureohydrolases ?\nLes conseils diététiques peuvent-ils prévenir ces troubles ?\nLe dépistage néonatal est-il recommandé ?\nLes antécédents familiaux influencent-ils la prévention ?\nLes vaccinations ont-elles un rôle dans la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Software&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Ureohydrolases",
"description": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?\nLes médicaments peuvent-ils aider à gérer les symptômes ?\nLa dialyse est-elle une option de traitement ?\nLes thérapies nutritionnelles sont-elles efficaces ?\nY a-t-il des traitements expérimentaux pour ces troubles ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Software&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Ureohydrolases",
"description": "Quelles complications peuvent survenir avec une hyperammoniémie ?\nLes troubles du comportement sont-ils une complication ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles réversibles ?\nLes complications peuvent-elles survenir à tout âge ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Software&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Ureohydrolases",
"description": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?\nL'alimentation joue-t-elle un rôle dans les facteurs de risque ?\nLes infections peuvent-elles aggraver les troubles ?\nLes facteurs environnementaux influencent-ils ces troubles ?\nLes médicaments peuvent-ils être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D014512?mesh_terms=Software&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en ureohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires mesurant les niveaux d'urée et d'ammoniac sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des ureohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques spécifiques et des analyses biochimiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les ureohydrolases ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la confusion, la fatigue et des troubles neurologiques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les ureohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations génétiques liées à des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Comment l'historique médical aide-t-il au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical peut révéler des antécédents familiaux de troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une accumulation d'urée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une hyperammoniémie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des troubles neurologiques, des céphalées et des convulsions."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus graves chez les nourrissons et les jeunes enfants."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une déficience en ureohydrolases ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme l'irritabilité, la léthargie et des troubles de l'alimentation peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans déficience enzymatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, d'autres conditions médicales peuvent provoquer des symptômes similaires."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux ureohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un dépistage précoce peut aider à gérer les risques."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils prévenir ces troubles ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils diététiques peuvent réduire le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Le dépistage néonatal est-il recommandé ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage néonatal peut identifier les troubles métaboliques précocement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles peuvent justifier un suivi médical accru."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les vaccinations ne préviennent pas directement les troubles liés aux ureohydrolases."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les troubles liés aux ureohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est une restriction protéique et des suppléments d'arginine."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à gérer les symptômes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments peuvent être prescrits pour réduire les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle une option de traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dialyse peut être utilisée pour éliminer l'excès d'ammoniac dans les cas graves."
}
},
{
"@type": "Question",
"name": "Les thérapies nutritionnelles sont-elles efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une thérapie nutritionnelle adaptée peut aider à gérer les niveaux d'urée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux pour ces troubles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux, comme la thérapie génique, sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une hyperammoniémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications graves incluent des lésions cérébrales et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles du comportement sont-ils une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles du comportement peuvent survenir en raison de l'accumulation d'ammoniac."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent gravement affecter la qualité de vie et nécessiter des soins constants."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir à tout âge ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent survenir à tout âge, mais sont plus fréquentes chez les jeunes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des ureohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et des régimes inappropriés."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans les facteurs de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en protéines peut augmenter le risque d'accumulation d'urée."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles aggraver les troubles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections peuvent exacerber les symptômes et augmenter les niveaux d'ammoniac."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils ces troubles ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs environnementaux comme la pollution peuvent affecter le métabolisme."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec le métabolisme de l'urée et des enzymes."
}
}
]
}
]
}
This study tests the impact of the addition of autonomous computed tomography (CT) interpreting software to radiologist assessment of pulmonary nodules....
Computed tomography scans for nodule assessment were identified retrospectively. Lung cancer risk factors, initial radiologist (RAD) report, Philips Lung Nodule software report (computer-aided nodule ...
In all, 100 patients were studied. Median maximal diameter of the largest nodule reported by RAD and RAD + CAD were similar at 10.0 and 9.0 mm, respectively (...
This study suggests that autonomous software use can alter radiologist assessment of pulmonary nodules such that suggested follow-up is altered....
Refactoring, a widely adopted technique, has proven effective in facilitating and reducing maintenance activities and costs. Nonetheless, the effects of applying refactoring techniques on software qua...
In 2018, PLOS Biology announced CellProfiler 3.0, which has become one of the most used pieces of image analysis software in biology. The rapid adoption of this software speaks to the importance of us...
The Collaborative Computational Project No. 4 (CCP4) is a UK-led international collective with a mission to develop, test, distribute and promote software for macromolecular crystallography. The CCP4 ...
Digital workflow is showing an increasing tendency in everyday dentistry. Accuracy is essential during digital dental workflows for all indication areas. The present study aimed to evaluate the effect...
3Shape Trios 3 Pod with software versions 18.1.2. (TRI3_1) and 20.1.2. (TRI3_2); 3Shape Trios 4 Move, version 19.2.2. (TRI4_1); and 3Shape Trios 4 Pod, version 20.1.1. (TRI4_2) were used to take direc...
In parameter 1 and 2, the newest model with the latest software (TRI4_2) reached the highest accuracy (31.06 ± 5.24 µm and 21.69 ± 7.50 µm). In parameter 3, an older generation scanner running legacy ...
Appropriate software updates can significantly increase the trueness and precision of intraoral scanner devices. With updated software, the older generation can match the accuracy level of latest equi...
The development of robotic applications necessitates the availability of useful, adaptable, and accessible programming frameworks. Robotic, IoT, and sensor-based systems open up new possibilities for ...
Metagenomic experiments expose the wide range of microscopic organisms in any microbial environment through high-throughput DNA sequencing. The computational analysis of the sequencing data is critica...
Different software programs are available for the evaluation of 4D Flow cardiovascular magnetic resonance (CMR). A good agreement of the results between programs is a prerequisite for the acceptance o...
Eight healthy subjects (27 ± 3 years, 3 women) were each examined on two 3T CMR systems (Ingenia, Philips Healthcare; MAGNETOM Skyra, Siemens Healthineers) with a standardized 4D Flow CMR sequence. Si...
SW-A and SW-C were the only software programs showing agreement for stroke volume (ICC = 0.96; E...
Of all tested software programs, only SW-A and SW-C can be used equivalently for determination of stroke volume, peak flow, and vessel area. Irrespective of the applied software and scanner, high intr...
Computed tomography perfusion (CTP) has played an important role in patient selection for mechanical thrombectomy (MT) in acute ischemic stroke. We aimed to investigate the agreement between perfusion...
We retrospectively reviewed a prospectively maintained MT database to identify patients with anterior circulation large vessel occlusion strokes (LVOS) involving the internal carotid artery or middle ...
In this analysis of 242 patients with LVOS, RAPID and Viz CTP relative cerebral blood flow (rCBF) < 30% values had substantial agreement (ρ = 0.767 [95% confidence interval [CI] = 0.71-0.81]) as well ...
Perfusion parametric maps of the RAPID, Viz CTP, and e-CTP software have substantial agreement in predicting final infarct volume in near-completely/completely reperfused patients. ANN NEUROL 2023;94:...
The MAGIX code (a French acronym standing for Automatic Gamma and X-ray Measurement) is a software developed to analyze γ/X spectra on the topic of severe accident diagnosis. Indeed, the gamma spectra...